These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

825 related items for PubMed ID: 16445721

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.
    Kern WV.
    Int J Clin Pract; 2006 Mar; 60(3):370-8. PubMed ID: 16494659
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.
    Steenbergen JN, Alder J, Thorne GM, Tally FP.
    J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644
    [Abstract] [Full Text] [Related]

  • 5. [Daptomycin: revitalizing a former drug due to the need of new active agents against grampositive multiresistant bacterias].
    Hernández Martí V, Romá Sánchez E, Salavert Lletí M, Bosó Ribelles V, Poveda Andrés JL.
    Rev Esp Quimioter; 2007 Sep; 20(3):261-76. PubMed ID: 18080024
    [Abstract] [Full Text] [Related]

  • 6. The use of daptomycin for Staphylococcus aureus infections in critical care medicine.
    Alder J.
    Crit Care Clin; 2008 Apr; 24(2):349-63, ix-x. PubMed ID: 18361950
    [Abstract] [Full Text] [Related]

  • 7. Daptomycin in the treatment of skin, soft-tissue and invasive infections due to Gram-positive bacteria.
    Johnson A.
    Future Microbiol; 2006 Oct; 1(3):255-65. PubMed ID: 17661638
    [Abstract] [Full Text] [Related]

  • 8. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.
    Kanafani ZA, Corey GR.
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):177-84. PubMed ID: 17402833
    [Abstract] [Full Text] [Related]

  • 9. Daptomycin: a review 4 years after first approval.
    Sauermann R, Rothenburger M, Graninger W, Joukhadar C.
    Pharmacology; 2008 Apr; 81(2):79-91. PubMed ID: 17940348
    [Abstract] [Full Text] [Related]

  • 10. Daptomycin, a lipopeptide antibiotic in clinical practice.
    Weis F, Beiras-Fernandez A, Schelling G.
    Curr Opin Investig Drugs; 2008 Aug; 9(8):879-84. PubMed ID: 18666036
    [Abstract] [Full Text] [Related]

  • 11. Pre-clinical experience with daptomycin.
    Hawkey PM.
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii7-14. PubMed ID: 18829726
    [Abstract] [Full Text] [Related]

  • 12. Treatment of staphylococcal infections with cyclic lipopeptides.
    Eisenstein BI.
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():10-6. PubMed ID: 18226085
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [New drugs; daptomycin].
    van Bronswijk H, Dubois EA, van Dissel JT, Cohen AF.
    Ned Tijdschr Geneeskd; 2007 Dec 15; 151(50):2777-8. PubMed ID: 18232197
    [Abstract] [Full Text] [Related]

  • 15. Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens.
    Das B, Sarkar C, Biswas R, Pandey S.
    Pak J Pharm Sci; 2008 Jan 15; 21(1):78-87. PubMed ID: 18166524
    [Abstract] [Full Text] [Related]

  • 16. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS, Watters AA, Fritsche TR, Jones RN.
    BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104
    [Abstract] [Full Text] [Related]

  • 17. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD.
    Eisenstein BI, Oleson FB, Baltz RH.
    Clin Infect Dis; 2010 Jan 01; 50 Suppl 1():S10-5. PubMed ID: 20067387
    [Abstract] [Full Text] [Related]

  • 18. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
    French GL.
    J Antimicrob Chemother; 2006 Dec 01; 58(6):1107-17. PubMed ID: 17040922
    [Abstract] [Full Text] [Related]

  • 19. [Daptomycin--a new antibiotic for the treatment of skin and soft tissue infections].
    Mathiesen L, Midtvedt T, Solberg CO.
    Tidsskr Nor Laegeforen; 2006 Sep 21; 126(18):2383-4. PubMed ID: 16998552
    [Abstract] [Full Text] [Related]

  • 20. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F, Aguilar L, González N, Giménez MJ, Torrico M, Alou L, Sevillano D, Vallejo P, Prieto J.
    J Antimicrob Chemother; 2007 Jun 21; 59(6):1185-9. PubMed ID: 17412725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.